RS174561 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"FADS1 FADS2 gene variants modify the association between fish intake and the docosahexaenoic acid proportions in human milk"
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Phosphatidylinositol (18:0_20:3) (a) levels | C | OR: 0.48 | 3E-99 | PubMed |
| Phosphatidylinositol (18:0_20:3) (a) levels | C | OR: 0.45 | 4E-85 | PubMed |
| Serum metabolite ratios in chronic kidney disease | C | OR: 0.55 | 5E-34 | PubMed |
| Plasma eicosapentaenoate (EPA; 20:5n3) levels in chronic kidney disease | C | OR: 0.24 | 7E-28 | PubMed |
| Sphingomyelin (d34:2) levels | C | OR: 0.17 | 7E-23 | PubMed |
| Serum metabolite levels | T | OR: 0.24 | 1E-21 | PubMed |
| Phosphatidylcholine (O-18:1_20:4) levels | C | OR: 0.27 | 4E-21 | PubMed |
| 1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels (elderly offspring) | — | OR: 0.11 | 4E-20 | PubMed |
| Docosanoid osbond acid, all-cis-4,7,10,13,16-DPA, FFA Docosapentaenoic Acid levels | — | OR: 0.16 | 7E-19 | PubMed |
| Lysophosphatidylethanolamine (18:1) [sn2] levels | C | OR: 0.2 | 5E-17 | PubMed |
| Phosphatidylcholine(36:3)_[M+H]1+/Phosphatidylethanolamine(39:3)_[M+H]1+/Phosphatidate(41:4)_[M+NH4]1+ levels | C | β: 0.056 | 6E-17 | PubMed |
| Phosphatidylcholine(37:4)_[M+H]1+/Phosphatidylethanolamine(40:4)_[M+H]1+/Phosphatidate(42:5)_[M+NH4]1+ levels | T | β: 0.084 | 6E-17 | PubMed |
| Phosphatidylcholine(38:4)_[M+H]1+/Phosphatidylethanolamine(41:4)_[M+H]1+ levels | T | β: 0.085 | 6E-17 | PubMed |
| Sphingomyelin(44:9)_[M+H]1- levels | C | β: 0.085 | 6E-17 | PubMed |
| Phosphatidylcholine(40:5)_[M+H]1+ levels | G | β: 0.063 | 6E-17 | PubMed |
| Cholesteryl ester(20:4)_[M+NH4]1+ levels | C | β: 0.052 | 6E-17 | PubMed |
| Phosphatidylcholine(38:5)_[M+H]1+/Phosphatidylethanolamine(41:5)_[M+H]1+/Phosphatidate(43:6)_[M+NH4]1+ levels | A | β: 0.041 | 6E-17 | PubMed |
| Phosphatidylcholine-O(36:5)_[M+H]1+/Phosphatidylcholine-P(36:4)_[M+H]1+ levels | T | β: 0.058 | 6E-17 | PubMed |
| Phosphatidylcholine(36:4)_[M+H]1+/Phosphatidylethanolamine(39:4)_[M+H]1+/Phosphatidate(41:5)_[M+NH4]1+ levels | G | β: 0.078 | 6E-17 | PubMed |
| Phosphatidylcholine(35:4)_[M+H]1+/Phosphatidylethanolamine(38:4)_[M+H]1+/Phosphatidate(40:5)_[M+NH4]1+ levels | T | β: 0.077 | 6E-17 | PubMed |